MONICA CAPP: Open Payments
NPI 1366428393 · WAKE FOREST, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,562 in 51 payments from 13 companies in 2025. Trend: 2023 $1,569 · 2024 $766 · 2025 $1,562
Food & beverage: $1,562
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $291 |
| Novo Nordisk Inc | 6 | $216 |
| E.R. Squibb & Sons, L.L.C. | 5 | $200 |
| ABBVIE INC. | 10 | $194 |
| Otsuka America Pharmaceutical, Inc. | 4 | $177 |
| Neurocrine BioSciences, Inc. | 10 | $136 |
| Axsome Therapeutics, Inc. | 2 | $115 |
| Lundbeck LLC | 3 | $75 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $65 |
| Vanda Pharmaceuticals Inc. | 2 | $43 |
Products named: Kerendia, REXULTI, COBENFY, VRAYLAR, INGREZZA, Ozempic, Auvelity, Wegovy.
Industry payments across NC — which companies pay providers there.
